Updated employee announcements, business news, awards and recognition in the industry today.
People
SynteractHCR has appointed four new Senior-Level Managers to its International Leadership Team. Miguel Fuentes joins as Executive Director, Service Delivery; Patrick F. Loebs, MSW, MPH, as Senior Regulatory Affairs Manager; Katharina Grote, as Finance Director, and Ewelina Mazur-Janik, MD, as Medical Monitor.
Worldwide Clinical Trials has appointed Margo Holland as its Vice President of Global Quality.
Bracket, a clinical trial technology and specialty services provider, announced the addition of Jennifer Peters to its team as the company's new Senior Vice President and General Manager for the Scientific Services division.
MedAvante, Inc., a provider of technology-based clinical trial services for treatments of central nervous system (CNS) diseases, announced that Susan Vallow, RPh MBA MA, has assumed a new position as Vice President, Patient eSolutions, joining MedAvante from GSK where she was Senior Director and Head of Patient Focused Outcomes.
Greenleaf Health, an FDA regulatory consulting firm that provides strategic and technical guidance to pharmaceutical and medical device companies, announced that John Jenkins, MD, has joined the firm as Principal, Drug and Biological Products.
INC Research, a global Phase I to IV CRO, announced the appointment of Eric Paul Pâques to the Company’s Board of Directors. Pâques joins the INC Research Board as an Independent Director and will be a Class I Director serving a term ending at the company’s 2018 Annual Meeting.
Almac Diagnostics has announced the appointment of Leeona Galligan, PhD, FRCPath to the position of Vice President, UK Operations.
Business
Chiltern announces the opening of its new process and technology center in Bangalore, India. In total, the company’s offices in India will be able to support more than 600 employees and give Chiltern substantial capacity to advance operations as needed.
endpoint Clinical launches the 500th clinical trial on its proprietary full-service IRT solution, PULSE.
Beaufort, LLC a CRO and consultancy, has obtained ISO 9001:2015 certification. The certification demonstrates that Beaufort provides quality services to the life sciences industry in its clinical research, regulatory affairs, quality and staffing solutions.
Awards
A 2017 IoT Evolution Business Impact Award will be presented to Sprint and its client, BioTelemetry, Inc., by TMC and Crossfire Media.
Recognition
PAREXEL has been named to Training Magazine’s annual “Training Top 125,” honored for developing creative and effective learning and development initiatives for its global workforce.
Worldwide Clinical Trials has been ranked as the industry’s #1 provider of Overall Contract Research, which includes non-clinical research services, in the “2017 Nice Insight Preclinical and Clinical Contract Research Survey.” The survey examines market perceptions of CROs using data collected from key industry executives.
KCR, a German CRO providing clinical development solutions for the pharma, biotech and medical device industries, celebrates its 20-year anniversary of contributing to clinical R&D.
Clintec International, announces the launch of its new brand identity to coincide with their 20th anniversary.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Landmark Phase III Trial Shows Keytruda Significantly Improves Event-Free Survival in LA-HNSCC
April 28th 2025Interim KEYNOTE-689 trial data show that perioperative Keytruda significantly lowers the risk of disease progression or recurrence in resectable, locally advanced head and neck squamous cell carcinoma, marking the first major clinical advance for this patient population in more than two decades.